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Summary A distal pancreatectomy is often performed simultaneously with splenectomy and total gastrectomy in the treatment of gastric
carcinoma to facilitate dissection of the lymph nodes around the splenic artery. However, the morbidity of partial pancreatectomy is high.
Patients undergoing pancreaticosplenectomy in conjunction with total gastrectomy are subject to leaks from the pancreatic stump, which may
cause further complications. We performed a retrospective analysis to evaluate the end results of simultaneous distal pancreatectomy with
total gastrectomy. The effect of distal pancreatectomy on survival was studied by examination of the records of 174 patients who underwent
splenectomy and total gastrectomy for gastric carcinoma. Of these, 93 underwent distal pancreatectomy. Prognostic factors were determined
and were examined in relation to the post-operative complications. There was no significant difference in the 5-year survival of the patients
who did or did not undergo distal pancreatectomy. There was no correlation between any prognostic factor and distal pancreatectomy. In
contrast, distal pancreatectomy was independently associated with post-operative complications. In this retrospective study, the addition of
distal pancreatectomy to splenectomy at total gastrectomy for patients with gastric cancer did not affect survival but was associated with
severe complications.
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The means of improving life expectancy in patients with gastric
cancer are early diagnosis and adequate surgical intervention.
Recently, in the treatment ofcarcinoma ofthe stomach, aggressive
lymph node dissection in conjunction with gastrectomy has been
reported to result in substantial improvements in survival
(Maruyama et al, 1987; Shiu et al, 1987). Distal pancreatectomy is
often performed simultaneously with total gastrectomy to facilitate
dissection of the lymph nodes around the splenic artery. There
havebeen reports in which distal pancreatectomy and splenectomy
resulted in better survival than splenectomy alone in gastric cancer
patients who underwent total gastrectomy (Nishioka et al, 1979;
Takagi et al, 1980).
However, the morbidity of a partial pancreatectomy is high
(Maruyama, 1979). Several investigators have demonstrated that
patients undergoing pancreaticosplenectomy in conjunction with
total gastrectomy are subject to leaks from the stump of the
pancreas (Cuschieri et al, 1996). This predisposes to subphrenic
abscess formation, dehiscence ofvisceral anastomoses and erosion
ofblood vessels in the area ofthe pancreas, resulting in high peri-
operative mortality rates. Thus, there is no consensus of opinion
regarding the therapeutic value of simultaneous distal pancreatec-
tomy in patients undergoing splenectomy with total gastrectomy
for gastric carcinoma.
We performed a retrospective analysis of 174 patients who
underwent splenectomy with total gastrectomy for gastric carci-
noma to evaluate the effect of distal pancreatectomy on survival.
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The post-operative morbidity in the patients who had a distal
pancreatectomy inconjunction with atotal gastrectomy and splenec-
tomy was compared with the morbidity in the patients who had
undergone only a splenectomy at the time ofthe total gastrectomy.
PATIENTS AND METHODS
Patients
From 1983 to 1994, 268 patients underwent total gastrectomy for
gastric carcinoma by staff members of the First Department of
Surgery, Kyoto Prefectural University of Medicine, Japan. Of
these patients, 93 (35%) underwent both splenectomy and distal
pancreatectomy with total gastrectomy, 81 (30%) underwent
splenectomy in conjunction with total gastrectomy and 94 (35%)
underwent only total gastrectomy. In this series, comparison was
made between 93 with pancreaticosplenectomy and 81 with
splenectomy alone.
Surgical technique
The surgical procedures were performed by several attending
surgeons on the faculty or by surgical fellows under their supervi-
sion. Patients with gastric carcinoma located in the middle or prox-
imal portion ofthe stomach underwent total gastrectomy using the
same technique. The tumours were graded using the UICC classifi-
cation ofmalignant tumours (4th edition) (Hermanek et al, 1987).
Clinicopathological findings
Information collected from the medical records included the age
and sex ofthe patient, as well as the size and histological grade of
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Table 1 Clinicopathological findings in the patients who underwent splenectomy and total gastrectomy with or without distal pancreatectomy
Variables Without distal pancreatectomy With distal pancreatectomy P-value
(n=81) (n=93)
Age (year, mean) 59.4 57.5 NS
Sex (female/male) 48/33 59/34 NS
Tumour size (mm, mean) 70.5 85.2 NS
Primary tumour (pTl/pT2/pT3/pT4) 7/32/35/7 1/29/41/22 <0.05*
Location (upper/middle/lower/whole) 43/20/4/14 43/26/2/22 NS
Regional lymph nodes (positive/negative) 36/45 34/59 NS
Distant metastasis (MO/Mi) 60/21 53/40 < 0.05*
UICC staging (la/lb/ll/lIla/lllb/IV) 6/19/13/14/13/16 1/10/10/16/13/43 < 0.05*
Residual tumour (RO/R1/R2) 63/4/14 53/8/32 < 0.05*
Operative time (min, mean) 290 322 <0.05*
Preoperative co-morbidity (positive/negative) 21/60 27/56 NS
Post-operative co-morbidity (positive/negative) 50/31 43/50 < 0.05*
Blood transfusion (positive/negative) 48/33 63/30 NS
NS, not significant. *Significant difference.
Table 2 Univariate analysis of prognostic variables for survival
Variables P-value
Age (over or under 65 years old) 0.791231
Sex (female/male) 0.381712
Tumour size (more or less than 5 cm) 0.008643*
Primary tumour (pTl/pT2/pT3/pT4) 0.000129*
Location (upper/middle/lower/whole) 0.010572*
Regional lymph nodes (NO/N1/N2) 0.000023*
Distant metastasis (MO/Mi) 0.000015*
Residual tumour (RO/R1/R2) 0.000006*
Operative time (more or less than 300 min) 0.422604
Preoperative co-morbidity (positive/negative) 0.419974
Blood transfusion (positive/negative) 0.519431
*Significant difference.
Table 3 Multivariate analysis of prognostic variables for survival
Variables Regression coefficient P-value
Tumour size 0.10024 0.31767
Cancer stage 0.63761 0.00025*
Location 0.08723 0.38813
Residual tumour 0.25584 0.05578
Distal pancreatectomy 0.04743 0.67422
*Significant difference.
the primary tumour, the depth ofinvasion and whether there were
regional lymph node or distant metastases. The UICC stage,
whether or not there was residual tumour, the operative time,
preoperative co-morbid conditions and blood transfusion require-
ments were also recorded.
Post-operative complications were reviewed. A complication
was not considered infectious unless confirmed by bacteriological
cultures.
Statistical methods
Statistical analysis was performed using the NAP system (Version
4.0) (Aoki, 1989). The first objective of the statistical analysis
was to examine the influence of each clinical, pathological and
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Figure 1 The 5-year survival rates for the patients who underwent total
gastrectomy and splenectomy with or without distal pancreatectomy. Using
the generalized Wilcoxon test, a significant difference is observed between
the post-operative survival rates for the patients who underwent total
gastrectomy with or without distal pancreatectomy. -, with distal
pancreatectomy (n = 93); - - -, without distal pancreatectomy (n = 81).
*Significant difference
treatment variable on survival following total gastrectomy.
Information obtained from the univariate analysis (log-rank test)
was applied to a survival analysis with covariates using the Cox
model of proportional hazards (Cox, 1972). To analyse the influ-
ence of distal pancreatectomy on survival following gastrectomy,
the Kaplan-Meier method and generalized Wilcoxon test were
performed.
The second objective ofthe statistical analysis was to assess the
dependence of the complications. Univariate analysis using the
Student's t-test and the chi-square test was performed to assess the
dependency ofthe post-operative complications on 12 explanatory
variables.
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Figure 2 The 5-year survival rates for the patients who underwent total gastrectomy and splenectomy with or without distal pancreatectomy at each cancer
stage (A, stage l; B, stage 11; C, stage l1l; D, stage IV). There are no significant differences between the post-operative survival rates for the patients who
underwent total gastrectomy with or without distal pancreatectomy using the generalized Wilcoxon test. -, with distal pancreatectomy [(A) n = 11, (B) n = 10,
(C) n = 29, (D) n = 43]; - -- , without distal pancreatectomy [(A) n = 25, (B) n = 13, (C) n = 27, (D) n = 16]
RESULTS
Clinicopathological findings
Significant differences were noted in the size of the primary
tumour, the prevalence of distant metastases and residual tumour,
the tumour stage, the operative time and the post-operative co-
morbidity between the patients who had and those who had not
undergone distal pancreatectomy (Table 1).
Prognostic factors
Ofthe 11 clinical and pathological variables identified by univariate
analysis, six were found to be independently predictive of survival
and were selected for the final proportional hazards regression.
Those variables were tumoursize, depth ofcancerinvasion, location
of the primary tumour and the presence of regional lymph node
metastases, distant metastases or residual tumour (Table 2).
Multivariate analysis showed that the only significant prognostic
factor for the patients with gastric carcinoma who underwent total
gastrectomy was cancer stage. Whether or not distal pancreatectomy
was performed was not an independent prognostic factor (Table 3).
Survival rates
The cumulative 5-year survival of the patients who underwent
total gastrectomy with or without distal pancreatectomy was 26%
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Table 4 Post-operative complications following total gastrectomy
Complication Without distal With distal
pancreatectomy pancreatectomy P-value
Cardiac 3 (3.7) 3 (3.2) NS
Pulmonary 4 (4.9) 4 (4.3) NS
Liver dysfunction 4 (4.9) 9 (9.6) NS
Renal dysfunction 1 (1.2) 2 (2.1) NS
Bleeding 1 (1.2) 2 (2.1) NS
Anastomotic leakage 10 (12.3) 14 (14.5) NS
Intestinal obstruction 4 (4.9) 3 (3.2) NS
Pancreatitis 1 (1.2) 2 (2.1) NS
Pancreatic fistula 2 (2.5) 11 (11.7) 0.01918*
Wound infection 5 (6.2) 7 (7.4) NS
Numbers in parentheses are percentages.
NS, not significant. *Significant difference.
and 51% respectively. Using the generalized Wilcoxon test, a
significant difference was observed between the post-operative
survival rates for the patients who underwent total gastrectomy
with or without distal pancreatectomy (P = 0.02368) (Figure 1).
Because cancer stage was an independent prognostic factor, and
because there was a significant difference in the number of
patients classified at each stage, post-operative survival analysis
was performed according to cancer stage. The cumulative 5-year
survivals for the patients who underwent total gastrectomy with
distal pancreatectomy were 100%, 20%, 20% and 14% for stages
I, II, III and IV respectively. In contrast, the cumulative 5-year
survivals for the patients who did not undergo distal pancreatec-
tomy were 95%, 39%, 45% and 7% for stages I, II, III and IV
respectively. There were no significant differences between the
post-operative survival rates at each stage for the patients who
underwent total gastrectomy with or without distal pancreatec-
tomy (P = 0.34291, 0.57208, 0.95854 and 0.49118 respectively)
(Figure 2).
Complication following total gastrectomy
Pancreatic fistulae were significantly more common following
total gastrectomy with distal pancreatectomy than after gastrec-
tomy without distal pancreatectomy (Table 4). To assess the
dependency of these variables, univariate analysis was performed
which revealed that the presence of residual tumour and the
performance of a distal pancreatectomy significantly affected the
incidence ofpost-operative complications (Table 5).
DISCUSSION
The extent ofthe lymph node dissection performed with a gastrec-
tomy for gastric carcinoma has been the topic of much discussion
(Soga et al, 1979, 1988; Gall et al, 1985). Pancreaticosplenectomy
was first performed by Brunschwig (1948) and McNeer et al
(1948) and Kajitani (Kajitani et al, 1964) in 1949 to dissect the
lymph nodes around the splenic hilum and splenic artery and was
advocated as the standard procedure forproximal gastric cancerby
Nakayama (1956) and Suzaki (1954). Because the lymphatics
along the splenic artery lie in the wall of the bursa, the lymph
nodes along the splenic artery can be completely dissected if
excision of the splenorenal ligament, dissection between Toldt's
fascia and the renal fascia and pancreaticosplenectomy are
Table 5 Univariate analysis of post-operative complications
Risk factor P-value Statistical method
Age 0.33410 t-test
Sex 0.71021 X2 test
Tumour size 0.60444 t-test
Primary tumour 0.33261 X2 test
Location 0.29180 X2 test
Lymph node metastasis 0.80449 X2 test
Cancer stage 0.36250 X2 test
Residual tumour 0.03465* x2 test
Operative time 0.13293 t-test
Preoperative co-morbidity 0.17097 X2 test
Blood transfusion 0.46169 X2 test
Distal pancreatectomy 0.04100* X2 test
*Significant difference.
performed (Hirayama et al, 1979). Maruyama et al (1987) have
recently reported a new procedure for complete dissection of the
lymph nodes around the splenic artery without sacrificing the
pancreas. However, Kanai (1967) has demonstrated, by examining
sequential sections of the distal pancreas and surrounding tissues,
that remnant nodes exist along the splenic artery in 74.7% of
patients. This suggests that organ resection in the absence of true
invasion is necessary to ensure the completeness of nodal dissec-
tion. Other authors have also demonstrated a discrepancy between
the macroscopic and microscopic involvement ofthe lymph nodes
along the splenic artery (Wada et al, 1970; Kawata et al, 1975).
Thus, distal pancreaticosplenectomy with total gastrectomy has
been widely performed as the standard procedure for the treatment
of proximal gastric cancer.
Kawaguchi et al (1983) have reported that nodal metastases
around the splenic artery are associated with nodal metastasis at
other sites. Sugimachi et al (1982) have reported that 85.4% of the
patients with nodal metastases at the splenic hilum or around the
splenic artery are incurable with surgery because of factors other
than the existence of these nodal metastases. In this study, the
effect of distal pancreatectomy was examined on the outcome of
patients undergoing total gastrectomy for gastric carcinoma. We
found no significant difference in post-operative survival in the
patients who had undergone total gastrectomy with or without
distal pancreatectomy.
The morbidity in patients who have undergone both a splenec-
tomy and a distal pancreatectomy with a total gastrectomy has
been reported to be greater than that in the patients who have
undergone splenectomy and gastrectomy alone (Lundell et al,
1986; Fortner et al, 1994). In the present study, significantly more
pancreatic fistulae were observed in the patients who had under-
gone distal pancreaticosplenectomy. Pancreatic fistulae are caused
by extravasation ofpancreatic fluid secreted by the remnant gland.
Although some investigators have reported the new method of
segmental occlusion of the pancreatic duct with prolamine to
prevent pancreatic fistula development following distal pancreate-
ctomy (Konishi et al, 1995), this procedure has not been widely
used clinically. In our study, stepwise logistic regression analysis
revealed that distal pancreatectomy independently correlates with
post-operative complications.
These results illustrate that the addition of distal pancreatec-
tomy to total gastrectomy and splenectomy for gastric cancer does
not improve survival but is associated with severe complications.
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